Ramucirumab
Modify Date: 2024-01-03 10:24:09
Ramucirumab structure
|
Common Name | Ramucirumab | ||
|---|---|---|---|---|
| CAS Number | 947687-13-0 | Molecular Weight | 6369.07 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C285H434N74O88S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RamucirumabRamucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors[1]. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D[2]. |
| Name | Ramucirumab |
|---|
| Description | Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors[1]. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D[2]. |
|---|---|
| Related Catalog | |
| Target |
VEGFR-2 |
| References |
| Molecular Formula | C285H434N74O88S2 |
|---|---|
| Molecular Weight | 6369.07 |